PROJECT 1 - Host Neuraminidases in Hemostasis and Sepsis
PROJECT 1 - Host Neuraminidases in Hemostasis and Sepsis
批准号:
10171428
负责人:
JAMEY MARTH
金额:
$54.93万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-07-15 至 2026-05-31
关键词:
AddressAgeAgingAlkaline PhosphataseAnti-Inflammatory AgentsAsialoglycoprotein ReceptorAsialoglycoproteinsBiochemicalBloodBlood Chemical AnalysisBlood CirculationBlood Coagulation DisordersBlood Coagulation FactorBlood PlateletsBlood ProteinsBlood VesselsBlood specimenCessation of lifeClinicalCoagulation ProcessCollaborationsDataDevelopmentDiagnosisDiagnosticDiseaseDisease OutcomeEnzymesExoglycosidasesFailureFunctional disorderFutureGalactoseGalactosidaseGeneticGlycoproteinsGlycoside HydrolasesGlycosidesHalf-LifeHealth Care CostsHematologyHemostatic functionHepatocyteHomeostasisHumanImmune responseImpaired cognitionInfectionInflammationInvestigationKineticsKupffer CellsLaboratoriesLectinLectin ReceptorsLigandsLinkLocationMalignant NeoplasmsMeasurementMeasuresMedical RecordsMembrane GlycoproteinsMetabolic Clearance RateMolecularMusNeuraminidaseOrgan failureOutcomePathogenesisPathway interactionsPatient-Focused OutcomesPatientsPhenotypePlasmaProcessProductionPrognostic MarkerProtein GlycosylationProteinsProteomeProteomicsRegulationResearchRoleSamplingSepsisSeverity of illnessSialic AcidsSignal TransductionSpecificityStratificationSurvivorsSyndromeTherapeuticThrombosisToxinUrineVascular Systemagedbasecomparativedesignhealthy volunteerhuman datahuman mortalityinsightintravital microscopymacrophagemortalitymouse modelpathogenpathogenic bacteriapatient health informationplatelet homeostasisprognosticprogramsproteostasisrate of changereceptorsenescenceseptic patientssialylationtherapeutically effectivevolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Coagulopathy and inflammation are the primary contributors to organ failure and patient death in sepsis.
Among the top five causes of human mortality worldwide, the number of sepsis cases diagnosed annually now
exceeds that of cancer. Among survivors, many suffer lifelong debilitation with cognitive decline from the
extensive vascular damage of the host response. Decades of failure in the development of effective
therapeutics for sepsis are reflected by the continuing high rate of patient mortality while many billions of
dollars of healthcare costs are expended annually. It has become evident that a greater mechanistic
understanding is needed regarding the molecular pathophysiology of this deadly syndrome. This project
addresses this need with proposed research of a recently discovered mechanism of glycoprotein remodeling,
senescence, and clearance that participates in disparate pathways modulating the coagulopathy and
inflammation in sepsis. We have linked the step-wise post-translational remodeling of nascent blood
glycoproteins by multiple glycosidases to increased protein age in circulation and to the formation of ligands for
endocytic lectin receptors. This process normally determines the half-lives and functions of multiple blood
components. Rates of this remodeling are altered in sepsis and among different blood components often linked
to pathogen identity. Increased rates of remodeling rapidly change the abundance and functions of key
glycoproteins including anti-inflammatory enzymes, coagulation factors, and platelets. Our findings are
consistent with the hypothesis that sepsis is not a singular disease mechanism and may be further understood
and stratified by analyzing alterations in host glycoprotein remodeling in the context of discrete pathogen
identities and associated toxins. This may have important implications for designing future therapeutic
approaches. The aims of this project encompass this perspective and the central hypothesis of the program:
Protein glycosylation and glycoprotein remodeling alter the coagulopathy and inflammation of sepsis. Research
proposed herein includes the identification and characterization of glycosidases and lectin receptors in the
blood and vascular systems contributing to blood component modulation and mechanisms of coagulopathy
and inflammation in sepsis. Blood glycoproteins desialylated by host Neu1 and Neu3 neuraminidases will be
identified and characterized including those targeted for increased endocytic clearance in sepsis. The related
process of platelet aging and clearance and its increase in sepsis will be further investigated. Recent findings
demonstrate a mysterious collaborative interaction between the Ashwell-Morell receptor of hepatocytes and
the macrophage galactose lectin of Kupffer cells. This project will also continue to acquire and analyze medical
records and blood samples provided by human sepsis patients and volunteers to achieve further translational
links yielding mechanistic, prognostic, and therapeutic insights. These enzymes and receptors together
contribute to distinct and overlapping molecular pathways in the stratification and pathogenesis of sepsis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Blood Glycoproteins by Lectin Receptors in Health and Disease
-
批准号:10658456
-
项目类别:
-
资助金额:$48.75万
-
财政年份:2023
-
负责人:JAMEY MARTH
-
依托单位:
Protein Sialylation and De-Sialyation in Cell Surface Glycoprotein Homeostasis and Disease
-
批准号:10211776
-
项目类别:
-
资助金额:$48.75万
-
财政年份:2021
-
负责人:JAMEY MARTH
-
依托单位:
Protein Sialylation and De-Sialyation in Cell Surface Glycoprotein Homeostasis and Disease
-
批准号:10552654
-
项目类别:
-
资助金额:$48.75万
-
财政年份:2021
-
负责人:JAMEY MARTH
-
依托单位:
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
-
批准号:10475586
-
项目类别:
-
资助金额:$267.7万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
CORE C - Infection and Inflammation Core
-
批准号:10171426
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
-
批准号:10641837
-
项目类别:
-
资助金额:$267.64万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
CORE A - Administrative Core
-
批准号:10171424
-
项目类别:
-
资助金额:$11.01万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
CORE C - Infection and Inflammation Core
-
批准号:10475593
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
-
批准号:9916805
-
项目类别:
-
资助金额:$254.35万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
CORE C - Infection and Inflammation Core
-
批准号:10641842
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
-
批准号:10171423
-
项目类别:
-
资助金额:$274.92万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
PROJECT 1 - Host Neuraminidases in Hemostasis and Sepsis
-
批准号:10641848
-
项目类别:
-
资助金额:$53.3万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
CORE A - Administrative Core
-
批准号:10641839
-
项目类别:
-
资助金额:$10.68万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
CORE A - Administrative Core
-
批准号:10475587
-
项目类别:
-
资助金额:$10.68万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
PROJECT 1 - Host Neuraminidases in Hemostasis and Sepsis
-
批准号:10475599
-
项目类别:
-
资助金额:$53.3万
-
财政年份:2016
-
负责人:JAMEY MARTH
-
依托单位:
Glycoprotein Remodeling in the Vasculopathy and Coagulopathy of Sepsis
-
批准号:8803032
-
项目类别:
-
资助金额:$76.7万
-
财政年份:2014
-
负责人:JAMEY MARTH
-
依托单位:
Glycoprotein Remodeling in the Vasculopathy and Coagulopathy of Sepsis
-
批准号:9271996
-
项目类别:
-
资助金额:$69.36万
-
财政年份:2014
-
负责人:JAMEY MARTH
-
依托单位:
Hepatic Lectin Receptors in Glycoprotein Homeostasis
-
批准号:8372941
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2012
-
负责人:JAMEY MARTH
-
依托单位:
Hepatic Lectin Receptors in Glycoprotein Homeostasis
-
批准号:8656367
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2012
-
负责人:JAMEY MARTH
-
依托单位:
Hepatic Lectin Receptors in Glycoprotein Homeostasis
-
批准号:8517148
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2012
-
负责人:JAMEY MARTH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: